Phase Ib study of pembrolizumab and XL888 in patients with advanced colorectal cancer

被引：0
作者：
Alese, O. [1 ]
Gbolahan, O. B. [1 ]
McCook-Veal, A. [1 ]
Coleman, K. [1 ]
Greene, E. [1 ]
Horvat, N. [1 ]
Switchenko, J. [1 ]
Lesinski, G. [1 ]
El-Rayes, B. F. [2 ]
机构：
[1] Emory Univ, Winship Canc Inst, Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Univ Alabama Birmingham, Hematooncol Dept, Birmingham, AL USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52P
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [41] Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).
    Saltos, Andreas Nicholas
    Tanvetyanon, Tawee
    Williams, Charles C.
    Haura, Eric B.
    Creelan, Ben C.
    Antonia, Scott Joseph
    Tchekmedyian, Nishan
    Goas, Kristen
    Mamplata, Trevor
    Thapa, Ram
    Chen, Dung-Tsa
    Beg, Amer A.
    Gray, Jhanelle Elaine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
    Cameron J. Herting
    Matthew R. Farren
    Yan Tong
    Ziyue Liu
    Bert O’Neil
    Tanios Bekaii-Saab
    Anne Noonan
    Christopher McQuinn
    Thomas A. Mace
    Walid Shaib
    Christina Wu
    Bassel F. El-Rayes
    Safi Shahda
    Gregory B. Lesinski
    Cancer Immunology, Immunotherapy, 2021, 70 : 3337 - 3348
  • [43] Phase I study of defactinib combined with pembrolizumab and gemcitabine in patients with advanced cancer.
    Wang-Gillam, Andrea
    Lockhart, A. Craig
    Tan, Benjamin R.
    Suresh, Rama
    Lim, Kian-Huat
    Ratner, Lee
    Morton, Ashley
    Huffman, Jess
    Marquez, Samantha
    Boice, Nicolas
    DeNardo, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [44] Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
    Nelson, Blessie Elizabeth
    Janku, Filip
    Fu, Siqing
    Dumbrava, Ecaterina I.
    Hong, David S.
    Karp, Daniel
    Naing, Aung
    Rodon, Jordi
    Tsimberidou, Apostolia
    Amaria, Rodabe N.
    Conley, Anthony
    Damodaran, Senthil
    Raghav, Kanwal P.
    Kreider, Brent L.
    Tung, David
    Varterasian, Mary
    Khazaie, Khashayarsha
    Piha-Paul, Sarina
    CANCER RESEARCH, 2023, 83 (08)
  • [45] Phase I/IB study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
    Kim, R.
    Imanirad, I.
    Carballido, E.
    Strosberg, J.
    Kim, Y.
    Kim, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S239 - S239
  • [46] Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
    Finn, Richard S.
    Ikeda, Masafumi
    Zhu, Andrew X.
    Sung, Max W.
    Baron, Ari D.
    Kudo, Masatoshi
    Okusaka, Takuji
    Kobayashi, Masahiro
    Kumada, Hiromitsu
    Kaneko, Shuichi
    Pracht, Marc
    Mamontov, Konstantin
    Meyer, Tim
    Kubota, Tomoki
    Dutcus, Corina E.
    Saito, Kenichi
    Siegel, Abby B.
    Dubrovsky, Leonid
    Mody, Kalgi
    Llovet, Josep M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 2960 - +
  • [47] Phase I study of defactinib combined with pembrolizumab and gemcitabine in patients with advanced cancer.
    Wang-Gillam, Andrea
    Lockhart, A. Craig
    Tan, Benjamin R.
    Suresh, Rama
    Lim, Kian-Huat
    Ratner, Lee
    DeNardo, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study
    Uldrick, Thomas S.
    Goncalves, Priscila H.
    Abdul-Hay, Maher
    Claeys, Alisa J.
    Emu, Brinda
    Ernstoff, Marc S.
    Fling, Steven P.
    Fong, Lawrence
    Kaiser, Judith C.
    Lacroix, Andreanne M.
    Lee, Steve Y.
    Lundgren, Lisa M.
    Lurain, Kathryn
    Parsons, Christopher H.
    Peeramsetti, Sharavi
    Ramaswami, Ramya
    Sharon, Elad
    Sznol, Mario
    Wang, Chia-Ching
    Yarchoan, Robert
    Cheever, Martin A.
    JAMA ONCOLOGY, 2019, 5 (09) : 1332 - 1339
  • [49] A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
    Kim, Richard D.
    Kovari, Bence P.
    Martinez, Maria
    Xie, Hao
    Sahin, Ibrahim H.
    Mehta, Rutika
    Strosberg, Jonathan
    Imanirad, Iman
    Ghayouri, Masoumeh
    Kim, Young-chul
    Kim, Dae Won
    EUROPEAN JOURNAL OF CANCER, 2022, 169 : 93 - 102
  • [50] A phase Ib study of pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver metastatic colorectal cancer (CRC).
    Turk, Anita Ahmed
    Lubner, Sam Joseph
    Uboha, Nataliya Volodymyrivna
    LoConte, Noelle K.
    Mulkerin, Daniel
    Kim, David H.
    Matkowskyj, Kristina
    Weber, Sharon M.
    Abbott, Daniel
    Eickhoff, Jens C.
    Bassetti, Michael F.
    Deming, Dustin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345